Table 5.
PFS | No. Patients | No. Events | Median PFS (Months) (95% CI) | p | HR (95% CI) | p |
hsa-miR-20b-5p | ||||||
<1293 | 26 | 24 | 8.1 (5.0–12.5) | 1.00 | ||
≥1293 | 26 | 20 | 14.0 (9.4–21.3) | 0.008 | 0.44 (0.24–0.82) | 0.010 |
hsa-miR-29b-3p | ||||||
<3138 | 25 | 23 | 8.2 (5.0–12.4) | 1.00 | ||
≥3138 | 27 | 21 | 14.9 (9.1–21.3) | 0.021 | 0.50 (0.27–0.91) | 0.024 |
hsa-miR-155-5p | ||||||
<0.73 | 32 | 30 | 8.3 (6.1–9.7) | 1.00 | ||
≥0.73 | 20 | 14 | 16.0 (10.2–23.0) | 0.007 | 0.42 (0.22–0.81) | 0.009 |
OS | No. Patients | No. Events | Median OS (Months) (95% CI) | p | HR (95% CI) | p |
hsa-miR-20b-5p | ||||||
<1293 | 26 | 23 | 11.6 (8.2–23.4) | 1.00 | ||
≥1293 | 26 | 17 | 28.8 (19.3–42.9) | 0.004 | 0.40 (0.21–0.77) | 0.005 |
hsa-miR-29b-3p | ||||||
<3138 | 25 | 22 | 15.5 (6.8–24.8) | 1.00 | ||
≥3138 | 27 | 18 | 31.7 (13.9–47.1) | 0.005 | 0.40 (0.21–0.78) | 0.007 |
hsa-miR-155-5p | ||||||
<0.73 | 32 | 27 | 13.5 (8.2–23.4) | 1.00 | ||
≥0.73 | 20 | 13 | 31.6 (21.8–42.9) | 0.024 | 0.47 (0.24–0.92) | 0.028 |